免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

临床试验

Early Detection of Complications During Immunotherapy for Haematological Malignancy

NCT:NCT06377059 · RECRUITING

NCT编号NCT06377059
状态RECRUITING
开始日期2024-12-02
完成时间2027-07-01
SponsorRigshospitalet, Denmark (OTHER)
First posted
Last updated

简要摘要

Aims * To identify patients that should remain admitted in hospital for more intense surveillance because of high risk for development of clinical complications * Expand the understanding of the interactions between physiology and immunology for the design of future projects and general knowledge Hypothesis Development of a risk model based on a combination of physiological and immunological parameters can contribute to early detection of patients at risk for clinical complications after anti-cancer treatment.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。

↑